Empagliflozin protects against isoprenaline-induced fibrosis in rat heart through modulation of TGF-β/SMAD pathway.

MLA

Elsayed, Mohammed, et al. “Empagliflozin Protects against Isoprenaline-Induced Fibrosis in Rat Heart through Modulation of TGF-β/SMAD Pathway.” Life Sciences, vol. 337, Jan. 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.lfs.2023.122354.

APA

Elsayed, M., Moustafa, Y. M., Mehanna, E. T., Elrayess, R. A., El-Sayed, N. M., & Hazem, R. M. (2024). Empagliflozin protects against isoprenaline-induced fibrosis in rat heart through modulation of TGF-β/SMAD pathway. Life Sciences, 337, N.PAG. https://doi.org/10.1016/j.lfs.2023.122354

Chicago

Elsayed, Mohammed, Yasser M. Moustafa, Eman T. Mehanna, Ranwa A. Elrayess, Norhan M. El-Sayed, and Reem M. Hazem. 2024. “Empagliflozin Protects against Isoprenaline-Induced Fibrosis in Rat Heart through Modulation of TGF-β/SMAD Pathway.” Life Sciences 337 (January): N.PAG. doi:10.1016/j.lfs.2023.122354.